The Hidden Dangers of Designer Benzodiazepines
- Harold Pierre, MD
- 7 days ago
- 16 min read
Designer Benzodiazepines: The Danger Behind Clonazolam, Flubromazolam and Fake Xanax
One of my patients was ordering his benzodiazepine from a website in Russia. He ended up in inpatient rehab. What stayed with me was a thought I had at the time: if he had walked into an emergency room instead of my office, the odds are good that nobody there would have known what they were looking at.
That is the problem with designer benzodiazepines. The patient looks like a straightforward benzo overdose. Then the treatment doesn't work the way anyone expects, and by the time the lab figures out what is actually in the blood, the patient has been on a ventilator for two days.
I want you to leave this page knowing one thing. These drugs are not safe, the evidence on that is not close, and if you or someone you love is taking them, you need help from someone who understands them.
What Is a Designer Benzodiazepine?
A designer benzodiazepine is a benzodiazepine built in a laboratory to sit outside the law. A chemist takes the core structure of a drug like alprazolam (Xanax) and changes one small piece of it. Swap a chlorine atom for a bromine atom. Add a fluorine. The molecule still fits the same lock in your brain, but it is technically a different compound, so it was never listed under the Controlled Substances Act.
That is the whole business model: create and sell illicit drugs but have legal cover.
The first designer benzodiazepines appeared on the drug market around 2007, and at least 29 of them have been reported to European drug monitoring since. Gudrun Høiseth and her colleagues at the Norwegian Institute of Public Health count more than 50 benzodiazepine-type substances circulating on the illicit market today. The names you are most likely to run into are clonazolam, flubromazolam, flualprazolam, etizolam, bromazolam, flubromazepam, diclazepam, deschloroetizolam and meclonazepam. None of them is approved for medicinal use anywhere, and none has ever been through a human safety trial.
There is one piece of history worth knowing, because it explains my patient. Phenazepam was developed in the Soviet Union in the 1970s as a real prescription drug for anxiety and alcohol withdrawal symptoms. Around the year 2000 it started turning up in the illegal drug market, sold under the name Bonzai and advertised as a "legal benzodiazepine." That sales pitch has never gone away. It just moved to new compounds and new websites.
How These Drugs Work in Your Brain
Benzodiazepines work on a neurotransmitter called GABA, short for gamma-aminobutyric acid. GABA is your brain's brake pedal, in other words, GABA is your brain's sedative. It slows down brain activity. A benzodiazepine sits on the GABA-A receptor and makes that brake work harder, which is why these drugs cause sedation, muscle relaxation and relief from anxiety.
I describe benzodiazepines to my patients as alcohol in pill form. Alcohol, barbiturates like phenobarbital, propofol and benzodiazepines all work on that same braking system, which is why they feel similar, why mixing them is so dangerous and why withdrawal from any of them can kill you. Designer benzodiazepines do the same thing. They just press harder.
Researchers using computer modeling of receptor binding predict that many designer benzodiazepines grip the GABA-A receptor more tightly than prescription benzodiazepines do. Fluorinating the molecule is part of the reason why. Canfield and colleagues compared alprazolam, flualprazolam and flubromazolam in rats and found that the two fluorinated compounds had longer half-lives and a much larger volume of distribution. In plain terms, the drug spreads deeper into body tissue and hangs around far longer. That combination of highly potent and longer duration is what turns a small mistake into an intensive care admission.
Just How Potent Are They?
A 27-year-old man in Poland bought flubromazolam from an online store and took about 3
milligrams. Three milligrams. He was found unconscious at home and arrived at the hospital in a deep coma with a Glasgow Coma Scale score of 3, which is the lowest score a living person can have. His pupils were pinpoint and unreactive. He was breathing six to eight times a minute and had to be intubated and put on a ventilator. His blood pressure was 80 over 40.
His creatine kinase, a muscle enzyme that leaks out when muscle tissue breaks down, came back at 15,960. Normal is under 200. He had pressure sores on his cheek, shoulder, forearm, hip, knee and ankle from lying motionless for hours before anyone found him. On day three, a repeat CT scan of his head showed hypoxic ischemic changes in both frontal regions and the left temporal region. That is brain injury from lack of oxygen. He was finally extubated on day four and transferred to the neurology department on day nine.
The team that treated him, led by Magdalena Łukasik-Głębocka at Poznan University of Medical Sciences, measured his blood level at 59 nanograms per milliliter and concluded that flubromazolam can produce deep coma with cardiorespiratory failure at concentrations as low as 43 nanograms per milliliter. For comparison, one reported case of a person taking half a milligram of flubromazolam produced considerable sedation. A single Xanax bar is 2 milligrams, and people take those by the handful believing they know what a benzodiazepine dose feels like.
Availability: How People Actually Get These Drugs
Three routes, and most people I talk to have used more than one.
Sold Online as a "Research Chemical"
Vendors label the product "not for human consumption" to stay on the right side of the law while everyone involved knows exactly what it is for. The drugs arrive as tablets, powder, pellets, capsules, blotters or liquids, and they are cheap. My Russian-website patient came through this route.
Bought as a Counterfeit Prescription Pill
This is now the most common way Americans run into these compounds without meaning to. Bromazolam has become the leading filler in fake Xanax. The DEA states plainly that bromazolam is often encountered in pill form and can be made to mimic the appearance of legitimate prescription drugs such as alprazolam. It has now turned up in all 50 states, and the National Forensic Laboratory Information System recorded 16,614 encounters with it as of February 2026.
Sold in Person as Something Else Entirely
Designer benzodiazepines are often mixed into other street drugs, especially fentanyl. A review of bromazolam-related deaths in Travis County, Texas found the drug in 112 deaths between 2021 and 2023. In 99 percent of those cases the person had taken more than one drug, and fentanyl was present in 82 percent, methamphetamine in 41 percent and cocaine in 28 percent.
Regulation keeps chasing this and keeps arriving late. The DEA temporarily placed etizolam, flualprazolam, clonazolam, flubromazolam and diclazepam into Schedule I on July 26, 2023. Bromazolam stayed legal for almost three more years. The DEA finally issued an emergency temporary scheduling order on March 16, 2026, placing it in Schedule I until March 2028 while permanent scheduling works its way through. By then a chemist somewhere had already moved on to the next molecule. That is how this drug market works, and enforcement will always be a step behind it.
What People Believe About These Drugs, and Why They Are Wrong
Here is where I want to spend real time, because the beliefs are doing as much damage as the chemistry. Researchers at the University of Hertfordshire and Swansea University, led by Amira Guirguis, pulled 1,183 public posts about etizolam, pyrazolam and flubromazepam from X and Reddit between 2016 and 2023 and analyzed what people were actually saying. Nearly a quarter of the posts were about buying and selling. Some were straight advertisements, including one that read: "Cheap original #Etizolam #Etibest! Register now and use coupon code: 510D to get a -10% discount." The rest is what worries me.
"It's a research chemical, so it's basically legal and basically safe"
Legal and safe were never the same thing. Bromazolam was legal in the United States until March 2026 and it was killing people the entire time. The DEA's own toxicology program detected bromazolam in 259 separate cases between April 2021 and February 2026. The person died in 201 of them. The "not for human consumption" label on the package is a legal shield for the seller. Read it as a warning about who you are buying from.
"I know the potency ratio, so I can dose it correctly"
Users trade conversion figures like they are working from a formulary. One post in the Guirguis study stated that etizolam is "approximately 10 times stronger than prescribed diazepam."
The ratio is useless. You are dosing a street drug of unpredictable purity, made in an unregulated lab, from a batch that may be nothing like the last one. There is no quality control you can trust. Knowing that a drug is ten times stronger than diazepam does not help you when you cannot measure what you are holding.
"Blacking out is just part of it"
Two real posts from that same study: "I blacked out on Xanax and etizolam for three days, I don't remember anything," and "first time I took etizolam i lost a week of my life." Both are written the way you would describe a rough weekend. Long-lasting amnesia is one of the most commonly reported effects of these compounds, and users have come to treat it as a feature of the drug. Losing a week of memory is a neurological event. When it happens to my patients I take it seriously, and so should you.
"I'll ask online whether this combination is safe"
Verbatim from the study: "Will taking 1000 mg of gabapentin and 3 lyrica and 9 mg of etizolam be dangerous?" That question was posted to strangers. It is a question for a physician, and the answer involves stacked central nervous system depression that can stop your breathing.
"Benzos alone don't kill you"
This is the most dangerous belief on the list and the one I hear most often. It comes from prescription benzodiazepines, where fatal overdose on the drug by itself genuinely is uncommon. It does not transfer. The 27-year-old in Poland took a designer benzodiazepine and ended up with brain injury from oxygen deprivation. In the systematic review by Gregory Noe and colleagues at Wake Forest, three of 35 designer benzodiazepine cases ended in death. The DEA notes at least four fatal bromazolam cases where the drug was found either alone or with no other psychoactive substance present.
"I can spot a fake bar"
You cannot. Counterfeit tablets are pressed specifically to pass the visual inspection you are performing. The CDC described three previously healthy young adults who swallowed pressed tablets of bromazolam that they believed were alprazolam. All three developed high blood pressure, a racing heart, dangerously high body temperature, multiple generalized seizures and damage to the heart muscle itself. They thought they were taking Xanax. Nothing about the pill told them otherwise.
"I'm not addicted, I'm treating my anxiety"
I hear this one from people who are not lying to me. They have real anxiety, they could not get a prescription or could not afford a psychiatrist, and they found something online that worked. Noe and his team found the same pattern in the published cases. Patients turned to designer benzodiazepines to self-medicate when their prescribed regimen failed them or when they had no access to psychiatric care. The problem is that you are treating a real illness with an unregulated substance of unknown potency, and dependence develops fast.
What a Designer Benzodiazepine Overdose Looks Like
The Wake Forest team reviewed every published case they could find and ended up with 27 reports covering 35 patients. The average age was 27. Men outnumbered women more than three to one. Just over half the cases involved a designer benzodiazepine alone, and the rest involved co-ingestions, most often cannabis or opioids.
The most common presenting sign was altered mental status, which ranged from mild agitation all the way to coma and seizures. The most common abnormal vital sign was a fast heart rate. Seven patients needed intubation and mechanical ventilation in an intensive care unit. Hospital stays ran from under five hours to 55 days. They described three patterns that clinicians should recognize.
The first is heavy sedation. The patient may be unable to protect their own airway and can present in frank coma, sometimes with low blood pressure, slow breathing and low oxygen. Some develop rhabdomyolysis and acute kidney injury, likely from lying still for so long.
The second is agitation and seizures. This can happen during intoxication or during withdrawal, and it can require phenobarbital when standard benzodiazepine dosing fails.
The third is the one that catches families off guard. The patient is sedated, then wakes up and seems fine, then crashes back into agitation and sedation. Flubromazolam produces three separate peaks in blood concentration as the body processes it. Somebody who looks recovered at hour six can be in trouble at hour twelve.
Naloxone Will Not Save Someone From This
Narcan reverses opioids. It does nothing to a benzodiazepine. In the Polish case, the team gave naloxone twice because the patient's pinpoint pupils and slow breathing looked like an opioid overdose. There was no response at all. Flumazenil, which is the actual benzodiazepine antidote, woke him to a Glasgow Coma Scale of 10 within minutes, and then he sank back to a 3 about half an hour later because the antidote wears off faster than the drug does.
This matters enormously for the fentanyl situation. When someone takes a counterfeit pill containing both fentanyl and bromazolam, naloxone reverses the fentanyl and leaves the benzodiazepine untouched. The person may still stop breathing. Give the naloxone anyway, because it treats the part it can treat, but call 911 and do not assume the emergency is over.
Why a Clean Drug Test Does Not Mean a Clean Patient
Standard urine drug screens are built to detect prescription benzodiazepines. Many designer benzodiazepines do not trigger them.
Noe and his colleagues make the point plainly: a patient can screen positive for opioids and THC while screening negative for benzodiazepines, and still be severely benzodiazepine-toxic. Identification usually requires liquid chromatography with mass spectrometry (LC-MS), which most emergency departments cannot run in real time.
It is not absolute. Some of these compounds do cross-react. The Polish patient's urine screen came back positive for benzodiazepines, which is what prompted the team to try flumazenil in the first place. Some designer benzodiazepines also break down into standard benzodiazepines, so diclazepam shows up as lorazepam on a test. The practical point for you: a negative benzodiazepine screen rules nothing out. If your family member is unresponsive and you know they have been buying pills online, say so out loud in the emergency department. That single sentence changes what the treating physician does next.
Forensic Toxicology Tells the Same Story
The Norwegian data is worth knowing because it comes from real people out in the world rather than from hospital case reports. Høiseth and her team analyzed 22,022 blood samples from criminal offenders in Norway over about three years. Designer benzodiazepines showed up in 77 cases. Sixty-nine of those were drivers suspected of driving under the influence, and 14 of those drivers had crashed. Flubromazolam was the most common compound, found in 25 cases, followed by flubromazepam in 24. Eighty-eight percent of the people involved were men, with a median age of 27.
Here is the number that captures the real-world risk. In only six of 77 cases was the designer benzodiazepine the only drug present. In the other 71 cases, the median person had three additional drugs on board, and one person had nine. Other benzodiazepines were present in 66 percent of those cases. THC was in 51 percent and amphetamine in 44 percent. Nobody is taking these compounds carefully by themselves.
Dependence, Tolerance and Withdrawal
Tolerance to designer benzodiazepines builds quickly. Users describe needing more within weeks, and they describe withdrawal that is worse and longer than what they experienced coming off prescription benzodiazepines. Aches, chills, tremors, cramping and seizures, sometimes running past a month. Withdrawal from a designer compound looks like withdrawal from any other GABA drug and can bring delirium, agitation, a racing heart and dangerously high body temperature.
Benzodiazepine withdrawal can kill you. That is true of Xanax and it is true of clonazolam. Seizures are the reason. Please do not stop these drugs abruptly on your own.
One more thing about who ends up here. Benzodiazepine misuse runs 3.5 to 24 times higher among people who already have a substance use disorder than in the general population. If you are in recovery from opioids or alcohol and you have started buying benzodiazepines online, it is the thing most likely to end your recovery.
The honest part that other articles skip: outpatient management of designer benzodiazepine dependence is genuinely hard, and the published record shows it.
The Wake Forest review found only three outpatient cases in the entire medical literature. In the first, a 30-year-old man was using clonazolam to self-medicate anxiety alongside an opioid use disorder. Repeated attempts to stop produced significant withdrawal and cravings. Valproic acid helped mildly. He relapsed on clonazolam three months later. In the second, a patient who had been self-medicating panic attacks for seven years was started on a clonazolam taper with gabapentin. He got to a 75 percent reduction and could not go further because of incapacitating anxiety and withdrawal. In the third, a 25-year-old man was started on gabapentin and trazodone and discharged, came back the same night with a seizure, was loaded with diazepam and then left against medical advice.
Three cases, three difficult outcomes. I am telling you this because you deserve to know what you are up against before you try to do it alone at home.
Treatment That Actually Works
Acute overdose is supportive care first. Protect the airway, support breathing and monitor closely. Flumazenil can reverse the sedation, and in a patient with confirmed or strongly suspected designer benzodiazepine ingestion who is hypoxic, the Wake Forest group considers the benefits to outweigh the risk of precipitating seizures. It wears off before the drug does, so one dose is never the end of the story.
For withdrawal, the standard approach is to cross-taper onto an FDA-approved long-acting benzodiazepine such as diazepam or chlordiazepoxide, then reduce the dose slowly on a schedule driven by symptoms rather than by the calendar. Structured scoring with the Clinical Institute Withdrawal Assessment for benzodiazepines helps guide dosing.
Two honest complications. First, nobody knows the correct dose equivalents between designer benzodiazepines and prescription ones, because the potency data in humans does not exist. Your doctor is estimating. Second, phenobarbital protocols are used when benzodiazepine dosing fails to control the withdrawal, and several published cases required exactly that.
Other medications appear across the case reports as add-ons: gabapentin, valproic acid, clonidine, dexmedetomidine, trazodone, naltrexone and antipsychotics for delirium or agitation.
Medication alone has a poor track record here, and this is the part I push hardest with patients. Adding cognitive behavioral therapy to a slow taper improves the odds of actually getting off the drug, and the strongest version of it is interoceptive exposure therapy. That approach works by deliberately bringing on the physical sensations you have learned to fear, a racing heart or shortness of breath, in a controlled setting until your nervous system stops treating them as an emergency. For someone who started taking benzodiazepines because of panic attacks, that is treating the actual problem instead of sedating it.
Inpatient treatment is the right call more often with these compounds than with prescription benzodiazepines. My patient from Russia went inpatient, and that was the correct decision.
What to Do If This Is Your Family Member
They need to be under the care of a knowledgeable physician. Say the words "designer benzodiazepine" to the treating physician. Bring the package, the pill, the powder or the website order confirmation if you have any of it. Physical evidence changes the workup. A negative benzodiazepine urine screen proves nothing, so don't let it reassure you, and don't let them detox at home. If they wake up and seem better, keep watching them. The rebound is real and it comes hours later.
And if the conversation you need to have feels impossible, start it anyway, without judgment. Noe and his colleagues put it well: patients need a nonjudgmental invitation to talk about what they have been buying. Most people I see using these drugs are treating anxiety or panic that nobody ever helped them with, and they found a website that would sell them something without asking questions.
Frequently Asked Questions
What are designer benzodiazepines?
Designer benzodiazepines are lab-made compounds built by modifying the chemical structure of prescription benzodiazepines like Xanax or Valium. They act on the same GABA-A receptor and produce sedation, muscle relaxation and amnesia. They were created to circumvent drug law enforcement rather than to treat anything, and none is approved for medicinal use. Common examples include clonazolam, flubromazolam, flualprazolam, etizolam and bromazolam.
Are designer benzodiazepines stronger than Xanax?
Many of them are far stronger. A 27-year-old man went into a deep coma with brain injury from lack of oxygen after taking about 3 milligrams of flubromazolam, and another reported case saw considerable sedation from half a milligram. A standard Xanax bar is 2 milligrams. On top of the potency, these compounds tend to last longer in the body, which prolongs the danger.
Will Narcan reverse a designer benzodiazepine overdose?
No. Naloxone reverses opioids only and has no effect on benzodiazepines. This becomes dangerous when a counterfeit pill contains both fentanyl and a designer benzodiazepine such as bromazolam, because the naloxone reverses the opioid and the sedation continues. Give naloxone anyway if an opioid may be involved, then call 911 immediately.
Will a drug test detect designer benzodiazepines?
Often it will not. Standard urine screens are designed for prescription benzodiazepines, and many designer compounds do not cross-react. Confirming them usually takes liquid chromatography with mass spectrometry, which most emergency departments cannot run quickly. A negative benzodiazepine screen does not rule out designer benzodiazepine toxicity.
Can you quit designer benzodiazepines on your own?
You should not try. Benzodiazepine withdrawal can cause seizures and can be fatal. Published outpatient cases show how hard this is, including one patient who could not get past a 75 percent dose reduction because of incapacitating withdrawal. Treatment normally involves cross-tapering to a long-acting prescription benzodiazepine under medical supervision, sometimes with phenobarbital, and often in an inpatient setting.
References
Noe G, McDuffee N, Li K, Munjal S. Clinical management of designer benzodiazepine intoxication: a systematic review. J Clin Psychopharmacol. 2025;45(2):116-126. doi:10.1097/JCP.0000000000001963
Łukasik-Głębocka M, Sommerfeld K, Teżyk A, Zielińska-Psuja B, Panieński P, Żaba C. Flubromazolam: a new life-threatening designer benzodiazepine. Clin Toxicol (Phila). 2016;54(1):66-68. doi:10.3109/15563650.2015.1112907
Høiseth G, Tuv SS, Karinen R. Blood concentrations of new designer benzodiazepines in forensic cases. Forensic Sci Int. 2016;268:35-38. doi:10.1016/j.forsciint.2016.09.006
Mullin A, Scott M, Vaccaro G, Floresta G, Arillotta D, Catalani V, Corkery JM, Stair JL, Schifano F, Guirguis A. Benzodiazepine boom: tracking etizolam, pyrazolam and flubromazepam from pre-UK Psychoactive Act 2016 to present using analytical and social listening techniques. Pharmacy (Basel). 2024;12(1):13. doi:10.3390/pharmacy12010013
Orsolini L, Corkery JM, Chiappini S, Guirguis A, Vento A, De Berardis D, Papanti D, Schifano F. 'New/designer benzodiazepines': an analysis of the literature and psychonauts' trip reports. Curr Neuropharmacol. 2020;18(9):809-837. doi:10.2174/1570159X18666200110121333
Edinoff AN, Nix CA, Odisho AS, et al. Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects. Neurol Int. 2022;14(3):648-663. doi:10.3390/neurolint14030053
Brunetti P, Giorgetti R, Tagliabracci A, et al. Designer benzodiazepines: a review of toxicology and public health risks. Pharmaceuticals (Basel). 2021;14(6):560. doi:10.3390/ph14060560
Canfield JR, Kisor DF, Sprague JE. Designer benzodiazepine rat pharmacokinetics: a comparison of alprazolam, flualprazolam and flubromazolam. Toxicol Appl Pharmacol. 2023;465:116459. doi:10.1016/j.taap.2023.116459
Ehlers PF, Deitche A, Wise LM, et al. Notes from the field: seizures, hyperthermia and myocardial injury in three young adults who consumed bromazolam disguised as alprazolam. MMWR Morb Mortal Wkly Rep. 2024;72(5253):1392-1393. doi:10.15585/mmwr.mm725253a5
Drug Enforcement Administration. Schedules of controlled substances: temporary placement of bromazolam in Schedule I. Fed Regist. March 16, 2026;91(50):12504-12509. Docket No. DEA-1420.
Drug Enforcement Administration. Schedules of controlled substances: temporary placement of etizolam, flualprazolam, clonazolam, flubromazolam and diclazepam in Schedule I. Fed Regist. July 26, 2023;88:48112.
About the author:
Harold Pierre, MD, is a board-certified anesthesiologist, board-certified addiction medicine specialist, and a concierge addiction doctor with over 27 years of experience. He is board-certified by the American Board of Anesthesiology, the American Board of Preventive Medicine and has extensive experience managing hormones. He is licensed in Florida, Texas, Oklahoma, Missouri (soon), Louisiana, and Arizona. If you are seeking care, you may schedule an appointment with him by calling or texting 918-518-1636. LinkedIn
This website is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician or another qualified medical professional. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Comments